Sanofi-Aventis CR`s Net Debt Growth reached 34.8 % in 2017. This is 17.8 % less than in the previous year.
Buy Net Debt Growth data for Sanofi-Aventis Czech Republic.
$19.99Buy all data for Sanofi-Aventis Czech Republic.
Buy annual subscriptions for all our products.
Company | Unit | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 |
Amgen Czech Republic | % | ... | ... | ... | ... | ... | ... | ... | ... | -17,482 | 83.3 | |||||||
Bayer Czech Republic | % | ... | ... | ... | -71.1 | -78.0 | -272 | 13.5 | 595 | |||||||||
GlaxoSmithKline Czech Republic | % | ... | ... | ... | -18.8 | 76.2 | 33.3 | -100 | 266,920 | |||||||||
Merck Czech Republic | % | ... | ... | 13.5 | -7.53 | 18.5 | -86.2 | -113 | ||||||||||
Novartis Czech Republic | % | 141 | -75.5 | -109 | -2,141 | -102 | ||||||||||||
Pfizer Czech Republic | % | ... | ... | -703 | -113 | -72.3 | 1,069 | -98.5 | ||||||||||
Roche Czech Republic | % | ... | ... | ... | -100 | -40,192 | 88.9 | 90.0 | 21.9 | ... | ||||||||
Sanofi-Aventis Czech Republic | % | ... | ... | ... | ... | -4.00 | 14.4 | -34.2 | -46.3 | -14.4 | ||||||||
Servier Czech Republic | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 41.6 | -14.0 | -44.7 | ||
Walmark | % | ... | ... | ... | -41.2 | 340 | -22.8 | -12.0 | 166 |